Analyst Reco. Morphic Holding, Inc.

Equities

MORF

US61775R1059

Market Closed - Nasdaq Other stock markets 01:30:00 02/05/2024 am IST			5-day change	1st Jan Change
27.97 ^USD	+2.57%		+1.01%	-3.15%

25/04	Morphic Holding, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
19/03	Morphic Holding Names Simon Cooper as Chief Medical Officer	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Citigroup Starts Morphic Holding With Buy Rating, $46 Price Target	08/12	MT
RBC Cuts Price Target on Morphic Holding to $76 From $80, Keeps Outperform, Speculative Risk	06/11	MT
BMO Capital Lowers Price Target on Morphic to $52 From $106, Maintains Outperform Rating	28/23/28	MT
Stifel Cuts Morphic Holding's Price Target to $33 From $61, Hold Rating Maintained	25/23/25	MT
BTIG Research Downgrades Morphic to Neutral From Buy	25/23/25	MT
Stifel Downgrades Morphic Holding to Hold From Buy, Adjusts Price Target to $61 From $69	09/23/09	MT
Berenberg Initiates Morphic Holding With Buy Rating, $75 Price Target	21/23/21	MT
BMO Capital Adjusts Price Target on Morphic Holding to $106 From $83, Maintains Outperform Rating	26/23/26	MT
RBC Raises Price Target on Morphic Holding to $80 From $75, Keeps Outperform, Speculative Risk	26/23/26	MT
Wells Fargo Adjusts Morphic Price Target to $80 From $67, Maintains Overweight Rating	25/23/25	MT
SVB Securities Raises Price Target on Morphic Holding to $56 From $45, Maintains Outperform Rating	08/23/08	MT
Wells Fargo Adjusts Price Target on Morphic Holding to $78 From $77, Maintains Overweight Rating	08/22/08	MT
RBC Raises Price Target on Morphic Holding to $75 From $70, Maintains Outperform, Speculative Risk Rating	03/22/03	MT
Analyst recommendations: Amazon, AstraZeneca, Glencore, Morphic, Phoenix Group...	07/22/07
Stifel Starts Morphic at Buy With $44 Price Target	07/22/07	MT
Wells Fargo Securities Adjusts Morphic Holding's Price Target to $77 From $79, Reiterates Overweight Rating	04/22/04	MT
RBC Cuts Price Target on Morphic to $70 From $76, Maintains Outperform Rating, Speculative Risk Qualifier	04/22/04	MT
Morphic Holding Shares Rise After SVB Securities Initiates Coverage at Outperform	20/22/20	MT
SVB Securities Initiates Morphic Holding at Outperform With $45 Price Target	20/22/20	MT
SVB Leerink Initiates Coverage on Morphic Holding With Outperform Rating, $45 Price Target	20/22/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Morphic Holding, Inc.

Equities

MORF

US61775R1059

Analyst Reco.

Filters